|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
TRIPROLIDINE |
R06AX07 |
DE
|
Not subject to prescription
|
|
None |
|
VALID
|
|
UBIDECARENONE |
C01EB09 |
DE
|
Not subject to prescription
|
|
None |
|
VALID
|
|
UNOPROSTONE |
S01EE02 |
DE
|
I
|
|
None |
|
VALID
|
|
UROFOLLITROPIN |
G03GA04 |
DE
|
I
|
|
None |
|
VALID
|
|
VELAGLUCERASE ALFA |
A16AB10 |
DE
|
I
|
|
None |
01-08-2011 |
VALID
|
|
VERNAKALANT |
C01BG11 |
DE
|
I
|
|
None |
01-08-2011 |
VALID
|
|
VINFLUNINE |
L01CA05 |
DE
|
I
|
|
None |
|
VALID
|
|
XIMELAGATRAN |
B01AE05 |
DE
|
I
|
|
None |
|
VALID
|
|
ZALCITABINE |
J05AF03 |
DE
|
I
|
|
None |
|
VALID
|
|
ZALEPLON |
N05CF03 |
DE
|
I
|
|
None |
|
VALID
|
|
ZANAMIVIR |
J05AH01 |
DE
|
I
|
|
None |
|
VALID
|
|
ZOFENOPRIL |
C09AA15 |
DE
|
I
|
|
None |
|
VALID
|
|
DAPSONE |
D10AX05 |
DE
|
POM
|
21-10-2019 |
UK/H/6673/002/DC |
12-03-2018 |
VALID
|
|
ADENOSINE |
C01EB10 |
DE
|
POM
|
21-10-2019 |
UK/H/0140/001/P/001 |
08-08-2018 |
VALID
|
|
CABERGOLINE |
G02CB03 |
DE
|
POM
|
21-10-2019 |
SE/H/0648/001/P/001 |
18-06-2018 |
VALID
|
|
VALGANCICLOVIR |
J05AB14 |
DE
|
POM
|
21-10-2019 |
PT/H/1182/001/E/001 |
11-02-2018 |
VALID
|
|
HALOPERIDOL |
N05AD01 |
DE
|
POM
|
21-10-2019 |
NL/H/4050/001/E/001 |
05-02-2018 |
VALID
|
|
EPOPROSTENOL |
B01AC09 |
DE
|
POM
|
21-10-2019 |
NL/H/3964/001/DC |
02-08-2018 |
VALID
|
|
IPRATROPIUM BROMIDE |
R03BB01 |
DE
|
POM
|
21-10-2019 |
NL/H/3040/001/P/001 |
15-07-2018 |
VALID
|
|
FLECAINIDE |
C01BC04 |
DE
|
POM
|
21-10-2019 |
NL/H/2428/001/P/001 |
05-03-2018 |
VALID
|
|
ALPRAZOLAM |
N05BA12 |
DE
|
POM
|
21-10-2019 |
NL/H/0338/001/P/001 |
12-03-2018 |
VALID
|
|
CISPLATIN |
L01XA01 |
DE
|
POM
|
21-10-2019 |
ES/H/0507/001/MR |
09-02-2018 |
VALID
|
|
TOLTERODINE |
G04BD07 |
DE
|
POM
|
21-10-2019 |
ES/H/0447/001/DC |
23-04-2018 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
DOPAMINE |
C01CA04 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
DANTROLENE |
M03CA01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006009 |
29-05-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
